The Stanford researchers developed a surgical strike to replace the nuke. They used an antibody called anti-CD117 to target ...
Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that it will present ...
Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback